A blood clot removal device for removing blood clots from the vascular system of a patient is implantable in the patient's body. The blood clot removal device comprises a blood flow passageway to be connected to the patient's vascular system to allow circulation of the patient's blood through the blood flow passageway, a filter provided in the blood flow passageway for collecting blood clots occurring in the blood flowing through the blood flow passageway, and a cleaning device for moving blood clots collected by the filter out of the blood flow passageway. By means of such blood clot removal device, the risk of blood clots reaching sensitive areas of the patient's body, such as the brain, is reduced.

A balloon catheter having an elongated catheter shaft defining a fluid drainage lumen and a balloon inflation lumen. The balloon catheter includes a fluid drainage port disposed about the distal end of the catheter shaft in fluid communication with the fluid drainage lumen, and a balloon inflation port disposed about the distal end of the catheter shaft in fluid communication with the balloon inflation lumen. A balloon portion is disposed about the distal end of the catheter shaft in fluid communication with the balloon inflation port. A release device is disposed in fluid communication with the balloon portion and the fluid drainage lumen, and includes an activating member. A tether is attached to the activating member of the release device. Tension applied to the tether activates the release device, enabling fluid flow from the balloon portion into the fluid drainage lumen and out of the body.

A fully implanted automatic disorder response system is devised to act as a backup “immune” system, automatically detecting and dispensing an enzyme, for example, deficient due to an inborn error of metabolism. In response to a disease, the agent released is one or more drugs. By directly pipeline-targeting agents through a closed system of drug reservoirs, fluid and electrical lines, and leak-free, durable, and safe tissue connectors to the site of disease, the system achieves a level of efficiency critically superior to the systemic dispersal of an agent into the circulation, fundamentally liberalizing the use of drugs. In comorbid disease, each morbidity is assigned to an arm or channel in a hierarchical control system. Beginning with symptomatic indicia sensors, data is analyzed and passed up through successively higher-level nodes that generate a cross-morbidity view passed up to an implanted microprocessor which effectuates a release of drugs calculated to optimize homeostasis.

A catheter (1) resector balloon (8) used in the treatment of any type of endoluminal-endobronchial tumoral or non-tumoral narrowing and occlusions and endovascular obstructions seen in the hollow tubular organs such as the trachea, esophagus, urinary tract, biliary tract, etc. and vessels, characterized in that, it comprises the following; at least one flexible pad section with pressure and proximity sensor and/or pad section without pressure and proximity sensor which provides soft stopping at the final wall section where the catheter (1) resector balloon (8) is applied in a soft, flexible and shock absorber manner at the tip (2) portion, prevents punctures, tears, bursts or vascular damages occurred in the tissues and vessels formed as a region, undesired complications, provides stopping without giving any damage to its location.

The present invention relates to a filtering device for removing particles from a bodily fluid of a patient, the filtering device being implantable in the patient's body. The device has a tube forming a main fluid passageway for bodily fluid, through which the bodily fluid of the patient passes when the tube is implanted in the patient, a filter connected to the tube and a filter cleaning device for cleaning the filter by moving particles collected by the filter out of the fluid passageway, wherein the filter cleaning device is adapted to replace the first filter in the fluid passageway with a second filter, thereby moving the particles collected by the first filter out of the fluid passageway.

A urinary catheter assembly is provided. The catheter assembly has a first outer package (20), which contains a second inner package (1). The second inner package includes a hydrophilic coated, intermittent catheter 82) and liquid swelling medium. The first outer package is made of a first material with a WVTR value between 1 and 6 g/(m.sup.2.Math.24 h) and the second inner package is made of a second material with a second WVTR value below 3 g/(m.sup.2.Math.24 h). An intermediate cavity (25) is defined inside the first outer package, but outside the second inner package. The first and second WVTR-values are balanced in such a way that the relative humidity (RH) is below 90% in the intermediate cavity. This prevents condensation on the inner surface of the first outer package and on the outer surface of the second inner package.

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

The present invention relates to a method of implanting a blood clot removal device in a patient's body, by cutting the skin of the patient's body, dissecting an area of the patient's vascular system, placing the blot clot removal device at the dissected area, and connecting a blood flow passageway of the blood clot removal device to the patient's vascular system to allow circulation of the patient's blood through the blood flow passageway.

A rigid package or container for a sterile pre-lubricated, ready to use female-length catheter with enhanced gel holders and simple constructions. A main body of the rigid container has a hollow interior which may receive a gel holder defining an inner cavity filled with a lubricating gel. The gel holder partly inserts into the main body and a tube of the catheter inserts through the gel holder into the main body with a proximal outlet projecting out of the gel holder so as to be graspable. Alternatively, the gel may be provided within the hollow interior of the main body. A rigid and closed cap seals to either the main body or the gel holder and closes the hollow interior of the main body.

A catheter (1) resector balloon (8) used in the treatment of any type of endoluminal-endobronchial tumoral or non-tumoral narrowing and occlusions and endovascular obstructions seen in the hollow tubular organs such as the trachea, esophagus, urinary tract, biliary tract, etc. and vessels, characterized in that, it comprises the following; at least one flexible pad section with pressure and proximity sensor and/or pad section without pressure and proximity sensor which provides soft stopping at the final wall section where the catheter (1) resector balloon (8) is applied in a soft, flexible and shock absorber manner at the tip (2) portion, prevents punctures, tears, bursts or vascular damages occurred in the tissues and vessels formed as a region, undesired complications, provides stopping without giving any damage to its location.